These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30946620)

  • 1. From the Editor-in-Chief's Desk.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):167. PubMed ID: 30946620
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children: A viewpoint by Raul R. Silva.
    Silva RR
    Drugs; 2006; 66(8):1127-8; discussion 1128. PubMed ID: 16789798
    [No Abstract]   [Full Text] [Related]  

  • 3. Flawed attention-deficit/hyperactivity disorder medication comparison.
    Adesman A
    Pediatrics; 2004 Oct; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
    [No Abstract]   [Full Text] [Related]  

  • 4. From the Editor-in-Chief's Desk.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):457. PubMed ID: 26262901
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attention deficit hyperactivity disorder in children].
    Bervoets L
    J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
    [No Abstract]   [Full Text] [Related]  

  • 6. From the Editor-in-Chief's Desk.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):301. PubMed ID: 25137187
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments on effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR food evaluation study.
    González MA; Polli JE; Morgan JA
    Curr Med Res Opin; 2002; 18(7):vii-x. PubMed ID: 12487510
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Quinn D; Bode T; Reiz JL; Donnelly GA; Darke AC
    J Clin Pharmacol; 2007 Jun; 47(6):760-6. PubMed ID: 17395894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.
    Anderson VR; Scott LJ
    Drugs; 2006; 66(8):1117-26. PubMed ID: 16789796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the Editor-in-Chief's Desk.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):601. PubMed ID: 26485085
    [No Abstract]   [Full Text] [Related]  

  • 11. From the editor-in-chief's desk.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):639. PubMed ID: 24350811
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit-hyperactivity disorder.
    Alloway TP
    Dev Med Child Neurol; 2011 Sep; 53(9):780. PubMed ID: 21518347
    [No Abstract]   [Full Text] [Related]  

  • 13. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
    Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical assessment of the methylphenidate transdermal system.
    Kowalik S; Minami H; Silva RR
    Drugs Today (Barc); 2007 Aug; 43(8):515-27. PubMed ID: 17925883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis.
    Faraone SV; Biederman J; Roe C
    J Clin Psychopharmacol; 2002 Oct; 22(5):468-73. PubMed ID: 12352269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose Methylphenidate Monotherapy for Features of Attention-Deficit/Hyperactivity Disorder Secondary to Hereditary Cerebellar Ataxia.
    Hu LY; Lin YL; Chang HS; Lu T; Lin WS
    CNS Neurosci Ther; 2015 Aug; 21(8):672-3. PubMed ID: 25976218
    [No Abstract]   [Full Text] [Related]  

  • 18. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.
    Baptista-Neto L; Dodds A; Rao S; Whitney J; Torres A; Gonzalez-Heydrich J
    Expert Opin Investig Drugs; 2008 Jan; 17(1):77-84. PubMed ID: 18095920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H
    J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens.
    Teicher MH; Polcari A; Foley M; Valente E; McGreenery CE; Chang WW; McKay G; Midha KK
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):416-31. PubMed ID: 16958567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.